Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
"Microscopic Analysis of Oncology and Cancer Research"
- Oncology Meet 2018

About

Allied academies invites all the participants across the globe to attend the  ‘21st Global Experts meeting on Oncology & Cancer Case Reports’ that will be held in Paris, France going to be held during February 26-28, 2018 .

 

Oncology Meet 2018 will be organized by Allied Academies. It is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies.  This publishing company was built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario(CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP) and The Canadian Association of Neurophysiologic Monitoring (CANM).


Why to attend Oncology Meet 2018?

 

Oncology Meet 2018 is the evidences/study done towards the treatment of cancer. It is a case series evidence based study which plays a crucial role in the field of medical research.

 

Oncology Meet 2018 will cover entire spectrum of the oncology, containing prevention, diagnosis, treatment, toxicities of therapy, supportive care, quality-of-life, and survivorship issues in the field of cancer & oncology. It will include the use of novel technologies, both in the arena of diagnosis and treatment in the fight against this dreadful disease. This conference will provide clinicians and researchers with a platform to disseminate their personal experiences to a wider public as well as to know interesting cases encountered by colleagues all over the world.

 

Oncology Meet 2018 will showcase the recent discoveries/advances performed towards the treatment of cancer. The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology. It is a perfect platform to share knowledge from biomedical researches to the implementation of those researches to acquire the seamless treatment procedures.


Target Audience

 

The conference will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and discuss new research in the field of cancer & oncology, including discussions on oncology.

  • Oncologists
  • Radiologists
  • Pathologists
  • Hematologists
  • Pathologists
  • Surgeons
  • Physicians
  • Virologists
  • Nurses
  • Scientists
  • Microbiologists & Epidemiologists
  • Pharmacologists
  • Delegates from Clinical Research Centers
  • Young Researchers working with Hospitals
  • Students

Sessions and Tracks

Oncology

 

Oncology is the study of tumor. A medical practitioner who treats oncology is known as an oncologist. Usually, an oncologist deals with care and treatment once a person is diagnosed with cancer. A medical oncologist treats growth utilizing chemotherapy or different medicines, for example, targeted therapy. A surgical oncologist expels the tumor and adjacent tissue amid an operation. A radiation oncologist treats malignancy utilizing radiation treatment. Oncologists may partition on the premise of the sort of treatment given to treat the malignancy. Molecular oncology is the study of chemistry of cancer and tumor cell at its molecular cell. Surgical oncology is the branch of oncology which manages the surgery connected to oncology. Gynaecologic oncology is one which concentrates on various growths of the female reproductive system.

 

Cancer

 

Cancers may be Benign or Malignant. Benign Cancers fail to spread to other tissues are non-life threatening. Malignant tumors are invasive and spread to other tissues within the body. Various types of tumors are reported till date and many are under research investigation. Some tumors are named after discoverer, which include Wilm's Tumor, Hodgkin's disease, Kaposi's sarcoma. Some Cancers are divided into groups according to the type of cell they start from; include Carcinomas are cancers of epithelial cells, Sarcomas represent tumors of connective tissues and Leukemias and Lymphomas refer to Cancers of blood cells. Organ specific Cancers include Lung Cancer, Brain Cancer, Heart tumors and many more. Endocrine Cancers include Pituitary Cancer, Thyroid Cancer, Parathyroid Cancer and Adrenal Cancers. Gastrointestinal cancers include Liver cancer, Gall bladder cancer, Pancreatic Cancer, Gastrointestinal Cancer, Colorectal Cancer, Rectal cancer, Anal cancer.

 

Oncology & Cancer Case Reports

 

Cancer is an uncontrolled division of cell which causes to death. Oncology & Cancer Case Reports refer to the study of the chemistry of cancer and tumors at the molecular scale. Oncology depends on diagnostic tools like biopsy or removal of bits of the tumour tissue and endoscopy for the gastrointestinal tract, imaging studies like X-rays, CT scanning, MRI scanning, ultrasound and other radiological techniques, Scintigraphy.

 

Carcinoma

 

Carcinoma is a kind of cancer that grows from epithelial cells. Specifically, a carcinoma is a cancer that begins in a tissue that lines the inner or outer surfaces of the body, and that generally arises from cells originating in the endodermal or ectodermal germ layer during embryogenesis. Carcinomas occur when the DNA of a cell is damaged or altered and the cell begins to grow uncontrollably and become malignant. Carcinoma case report refers to the study of symptoms, signs, diagnosis, and treatment of the patients suffering from carcinogenesis.

 

Tumour Biology

 

Cancer cells act as self-governing cells, growing without control to form tumors. Tumors grow in a series of steps. The first step is hyperplasia. These cells appear normal, but changes have occurred that result in some loss of control of growth. The second step is dysplasia, resulting from further growth, accompanied by abnormal changes to the cells. The third step requires additional changes, which result in cells that are even more abnormal and can now spread over a wider area of tissue. These cells begin to lose their original function; such cells are called anaplastic. The last step occurs when the cells in the tumor metastasize, which means that they can invade surrounding tissue, including the bloodstream, and spread to other locations. This is the most serious type of tumor, but not all tumors progress to this point. Non-invasive tumors are said to be benign.

 

Clinical Trials & Oncology Reports

 

People with cancer are frequently offered the option of treatment in a clinical trial. In a clinical trial, patients can be certain of receiving excellent treatment with the possibility of receiving additional new treatments that could help them. Their participation also helps contribute to improved treatments for future patients. Clinical trials may include hundreds or even thousands of people. That means it can take a long time to get results. This process is also on-going. As doctors learn and study new information, they add new care standards or replace old ones. Clinical trials are the only accepted way scientists can find out if new treatments work better than standard ones.

 

Cancer Prognosis & Prevention

 

Cancer survival rates or survival numbers tell the percentage of people who survive an assured type of cancer for a specific amount of time. Cancer statistics often use an overall five-year survival rate. Cancer survival rates are maintained on research from information gathered on hundreds or thousands of individual with a particular cancer. An overall survival rate includes individuals of all ages and health conditions who have been diagnosed together with cancer, together with those diagnosed terribly early and people diagnosed terribly late. Making the people educate about the cancer can prevent the death of the through cancer. There are many cancers which can be cure at early stages.

 

Case Reports on Surgical Oncology

 

Surgical oncology is the branch of surgery applied to oncology; it focuses on the surgical management of tumors, especially cancerous tumors. As one of some modalities in the management of cancer, the specialty of surgical oncology, before modern medicine the only cancer treatment with a chance of success, has grown in points similar to medical oncology, which grew out of hematology, and radiation oncology, which grew out of radiology. The proliferation of cancer centers will continue to feast the field, as will developments in minimally invasive techniques, palliative surgery, and neo-adjuvant treatments

 

Rare Cancers

 

There is some cancer which is rarely found. According to the definition, rare cancers are identified as those with an incidence of less than 6 per 100,000 persons per year. Using this definition would help minimise the risk of mistaking a rare cancer such as testicular cancer, which is frequently cured and thus has a rather high prevalence, for a common cancer, or a frequent cancer such as small-cell lung cancer, which has a low life expectancy and thus a low prevalence, for a rare cancer. Some of the examples of rare cancer are: Actinic cell adenocarcinoma of the parotid gland, Cervix small cell, Children cancers and chordoma.

 

Clinical Oncology & Radiation Oncology

 

Clinical oncology consists of three primary disciplines: medical oncology which refers to the treatment of cancer with medicine, including chemotherapy, surgical oncology which refers to the surgical aspects of cancer including biopsy, staging, and surgical resection of tumors, and radiation oncology the treatment of cancer with therapeutic radiation. These are the main disciplines which are used by the doctors to treat the oncology patients. Chemotherapy is well known method for the treatment of cancer.

 

Oncology Nursing

 

Nursing is one of the most important parts of medical care. Oncology nurses practice in a variety of settings, including hospitals, outpatient clinics, private practices, long-term care facilities and more. The scope of oncology nursing spans from prevention and early detection, to treatment such as surgical oncology, radiation oncology, medical oncology, through symptom management and palliative care. Thoughtful for cancer patients is very rewarding. It’s also a physically, mentally and emotionally difficult job. Oncology nurses must keep track of several details throughout the day for each patient and they likely have to tend to several patients each day. One mistake could adversely affect a patient’s health, so their attention to detail is critical.

 

Gynecologic Oncology

 

Gynecologic Cancer is the field of medicine that focuses on cancers of the female reproductive system. As experts they have wide training in the diagnosis and treatment of this cancer. In 2012, there were about 4.7 million cases of women cancer worldwide in which 54% cases arose in less developed countries. Although the occurrence and mortality from Gynecologic cancer are major, other cancers are very uncommon. Primary cancers of the vulva, vagina, placenta and adnexa total 0.6% of all woman cancers. In the world 90,000 women are identified with Gynecologic Cancer each year. Early detection of tumour biology and treatment of Gynecologic Cancer in younger women is more as compared to older women.

 

Heamatologic Oncology

 

Hematology additionally spelled as Heamatology, is the division of medicine involved with the learning, diagnosis, treatment, and bar of diseases associated with the blood. Hematology includes the learning of etiology. It includes treating diseases that have an effect on the assembly of blood and its components, like blood cells, blood proteins, bone marrow, hemoglobin, platelets, blood vessels, spleen, and also the mechanism of clotting. Physicians focused in hematology are referred as Heamatologists. There are varied disorders that people are affected by. Some of those dissimilar types of blood conditions that are checked out embrace include anemia, hemophilia, general blood clots, bleeding disorders, etc. As for connected blood cancers such as leukemia, myeloma, and lymphoma, these are a lot of serious cases that require to be diagnosed.

 

Oncology Practices

 

Cancer is a leading cause of death worldwide, around 8.2 million deaths in 2012-2013. In 2010, the global cancer market was valued around $55 billion, with forecasted Compound Annual Growth Rate growth to approximate of $80 billion by 2016. The seven major cancer markets US, France, Italy, Spain, United Kingdom and Japan) represented around 80% of the 2010 global cancer market (around $42 billion). The US dominated 2010 sales with a market share of 39.5% and the leading ten companies of the global cancer market represented 86.1% ($46 billion) of the total market.

 

Reports on Differential Diagnosis methods

 

Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. There are many types of the diagnosis methods they are as follows: Biopsy, Endoscopy, Pap test, imaging studies. Biopsy is a test where a small sample of tissue is taken from the suspected cancer with the help of a fine tipped needle. The tissues are then examined under a microscope for the presence of cancer cells. Endoscopy In this imaging technique a tinny, flexible tube with a tiny camera on the end is inserted into the body cavities. This allows the doctors to view the suspicious area. There are many types of scopes, each designed to view particular areas of the body. Pap test Pap test is a routine test where a sample of cells from a woman’s cervix is examined under the microscope. This helps identify changes in the cells that could indicate cervical cancer or other conditions. Imaging studies there are several imaging techniques. These include X rays, CT scans, MRI scans of various parts of the body. X-rays are the most common imaging techniques and they may be made more specific by using a Barious enema. This is used for detection of stomach and small intestinal growths and cancers. Mammogram is an X-ray of the breasts used to screen for and/or detect breast lumps and growths. A CAT scan (computerized axial tomography) uses radiographic beams to create detailed computerized pictures. It is more precise than a standard X-ray.

 

Novel Diagnostics Approaches

 

There are some new diagnostics methods which are uses by the doctors to treat the cancer they are as follow Linear Accelerators This technology is the platform for IMRT and IGRT, permits specialists to deposit variable amounts of radiation in a highly controlled fashion. The Linear Accelerator treatment machine uses a computerized tool to shape the radiation beam in unity with the improved treatment plan. The implement can constantly move to change both the shape and intensity of the beam to fit each patient and each tumor size and form. IMRT (Intensity Modulated Radiation Therapy) Intensity Modulated Radiation Therapy offers potential benefits for the treatment of many cancer types. The technology enables radiation oncologists to bombard cancer cells with higher doses of radiation than those previously delivered, while keeping exposure to the normal tissue at a minimum. Image Guided Radiation Therapy (IGRT) provides a unique treatment advantage: it has the potential to achieve both unparalleled tumor control and normal tissue sparing. The radiation beam can be shaped to match the dimensions of a tumor and a high dose of radiation can be delivered to a malignancy without harming surrounding normal tissue. Tumors can move, both during a radiation treatment session and from one treatment session to another, as a result of normal internal organ action and small differences in the way the patient is positioned for treatment. Three-Dimensional conformal Radiation Therapy Using the wide-boar CT simulator, a device that allows physicians to perform three-dimensional mapping for precision and pinpoint targeting of tumors, radiation oncologists can perform simulations with much greater speed (15-30 minutes vs. 1-3 hours needed for conventional simulation), and much greater comfort for the patient. High-Dose Rate Brachytherapy Another means of delivering concentrated doses directly to the tumor site without affecting adjacent tissues and organs, this method utilizes a catheter as the means for the radioactive source to travel to the site.

 

Reports in Investigation Studies

 

Carcinoma is a kind of cancer that grows from epithelial cells. Specifically, a carcinoma is a cancer that begins in a tissue that lines the inner or outer surfaces of the body, and that generally arises from cells originating in the endodermal or ectodermal germ layer during embryogenesis. Carcinomas occur when the DNA of a cell is damaged or altered and the cell begins to grow uncontrollably and become malignant. Carcinoma case report refers to the study of symptoms, signs, diagnosis, and treatment of the patients suffering from carcinogenesis.

 

Cancer Management

 

Cancer management covers the risk factors, symptoms, diagnosis, staging, and treatment of the cancer. This is widely related to the care of the patients whoever are suffering from cancer. This process is taking care of the cancer patients daily activates. It’s also dealing with the support emotionally to the cancer patients.

 

Supportive Care in Oncology

 

Care given to expand the quality of life of patients who have a serious or severe disease. The goal of supportive care is to prevent or treat as early as possible the symptoms of a disease, side effects caused by treatment of a disease, and psychological, social, and spiritual problems related to a disease or its treatment. Also called comfort care, palliative care and symptom management. The Supportive Care Centre accepts patients of all cancer diagnoses, at any point within their disease and/or treatment process. It’s involves in care of physical or emotional symptoms, improving function and reducing disability.

 

Toxicology and Cancer Biology

 

Toxicology and Cancer Biology the survey is being done in ecotoxicology, transmissible toxicology and Cancer science. The Research Collection actively supports aspects of basic research into environmental, human and animal health problems as they relate to the disciplines of Toxicology and Cancer Biology. The Research Cluster effectively underpins parts of essential research into natural, human and animal medical problems as they recognize with the orders of Toxicology and Cancer Biology. Several issues along the U.S.-Mexico border relate to, but are by no means limited to heavy metal contamination and exposure, water pollution from both domestic and international sources, air pollution and the associated acute and chronic exposure to environmental contaminants originating from the deposition of small molecules that, collectively, pollute the air.

 

Cancer Staging

 

Cancer staging can be divided into a clinical stage and a pathologic stage. In the Tumor, Node, Metastasis system, clinical stage and pathologic stage are denoted by a small "c" or "p" before the stage. This staging system is used for most forms of cancer, except brain tumors and hematological malignancies. Clinical stage is based on all of the available information obtained before a surgery to remove the tumor. Thus, it may include information about the tumor obtained by physical examination, blood tests, radiologic examination, biopsy, and endoscopy. Pathologic stage adds additional information gained by examination of the tumor microscopically by a pathologist after it has been surgically removed. Because they use different criteria, clinical stage and pathologic stage often differ. Pathologic staging is usually considered to be more accurate because it allows direct examination of the tumor in its entirety, contrasted with clinical staging which is limited by the fact that the information is obtained by making indirect observations of a tumor which is still in the body. However, clinical staging and pathologic staging often complement each other.

 

Cancer Prognosis

 

Different factors affect a person's prognosis. Some of the most important are the type and location of the cancer, the extent to which the cancer has metastasized, or spread and how abnormal the cancer cells look and how quickly the cancer is likely to grow and spread. In addition, for cancers of the blood or bone marrow such as leukemias and lymphomas, the presence of chromosomal abnormalities and abnormalities in the patient's complete blood count can affect a person's prognosis. Researchers usually give survival statistics as rates. The rates describe the percentage of people with a specific cancer type who will be alive a certain time after diagnosis. Survival rates can describe any given length of time.

 

Cancer Screening

 

Cancer screening aims to detect cancer before symptoms appear. This may involve blood tests, urine tests, other tests, or medical imaging. The benefits of screening in terms of cancer prevention, early detection and subsequent treatment must be weighed against any harm. Universal screening, mass screening or population screening involves screening everyone, usually within a specific age group. Selective screening identifies people who are known to be at higher risk of developing cancer, such as people with a family history of cancer. Screening can lead to false positive results and subsequent invasive procedures. Screening can also lead to false negative results, where an existing cancer is missed. Controversy arises when it is not clear if the benefits of screening outweigh the risks of the screening procedure itself, and any follow-up diagnostic tests and treatments.

 

Carcinogenesis and Mutagenesis

 

Carcinogenesis is the formation of a cancer, whereby normal cells are distorted into cancer cells. The process is characterized by changes at the cellular, genetic, and epigenetic levels and abnormal cell division, in some cancers developing a malignant mass. Cell division is a physiological procedure that occurs in almost all tissues and under a variety of circumstances. A mutagen is a physical or chemical agent that changes the genetic material, usually DNA, of an organism and thus increases the frequency of mutations above the natural background level. As many mutations can cause cancer, mutagens are therefore also likely to be carcinogens, although not always necessarily.

 

Cancer Pain Management

 

Cancer pain treatment purposes to release pain with slight adverse treatment effects, allowing the person a good quality of life and level of function and a relatively painless death. Though 80-90 percent of cancer pain can be controlled, half of the people with cancer pain in the developed world and more than 80% of people through cancer worldwide receive less than best care. Cancer changes over time, and pain managing needs to reflect this. Some different types of treatment may be required as the disease progresses. Pain managers should clearly explain to the person the cause of the pain and the various treatment possibilities, and should consider, as well as drug therapy, directly modifying the underlying disease, raising the pain threshold, interrupting, destroying or stimulating pain pathways, and suggesting lifestyle modification.

 

Oncology Nursing and Care

 

The Oncology Nursing Certification Corporation offers several different options for board certification in oncological nursing. Certification is a voluntary process and certifies a nurse takes proper experience and knowledge of a specialty area and has kept up-to-date in his or her education. In this certification is of different ways they are Basic, Specialty. It is granted for four years, after which it must be renewed by taking a recertification test or by earning a certain number of continuing education credits. To become certified, nurses must have an RN license, meet specific eligibility criteria for nursing experience and specialty practice, and must pass a multiple-choice test.

 

Cell Signaling and Cancer Therapy

 

Cell signaling is part of some communication procedure that governs simple activities of cells and coordinates all cell actions. The capability of cells to perceive and correctly respond to their microenvironment is the basis of development, tissue repair, and immunity as well as normal tissue homeostasis. Cancer can be treated by surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy and synthetic lethality. The choice of therapy depends upon the location and grade of the tumor and the phase of the disease, as well as the common state of the patient. A number of experimental cancer treatments are also under development.

 

Cancer Awareness and Survival

 

Breast cancer awareness is an effort to raise awareness and reduce the stigma of breast cancer through education on symptoms and treatment. Supporters hope that better knowledge will lead to earlier discovery of breast cancer, which is associated with higher long-term survival rates, and that money raised for breast cancer will produce a reliable, permanent cure. Cancer survival rates vary by the type of cancer, stage at diagnosis, treatment given and many other factors, including country. In general survival rates are improving, although more so for some cancers than others. Survival rate can be measured in several ways, median life expectancy having advantages over others in terms of meaning for people involved, rather than as an epidemiological measure.

 

Cancer Clinical Trials and Case Reports

 

Clinical trials are experiments or observations done in clinical research. In medicine, a case report is a detailed report of the symptoms, signs, diagnosis, treatment, and follow-up of an individual patient. Cancer case reports refer to the investigation of the chemistry of cancer and tumors at the molecular scale. Cancer depends on diagnostic tools similar biopsy or removal of bits of the tumor tissue and endoscopy for the gastrointestinal tract, imaging studies like X-rays, CT scanning, MRI scanning, ultrasound and other radiological techniques, Scintigraphy.

 

Psychological & Social Aspects

 

Social psychology is the scientific study of how people's thoughts, feelings, and behaviors are influenced by the actual, imagined, or implied presence of others. In this definition, scientific refers to the empirical method of investigation. Social psychologists typically explain human behavior as a result of the interaction of mental states and immediate social situations. Social cognition is a growing area of social psychology that studies how people perceive, think about, and remember information about others. Much research rests on the assertion that people think about the other people differently from non-social targets.

 

Lifestyle and Nutrition

 

Dietary factors are recognized as having a significant effect on the risk of cancers, with different dietary elements both increasing and reducing risk. Diet, physical inactivity, and obesity may be related to up to 30–35% of cancer deaths. While many dietary recommendations have been proposed to reduce the risk of cancer, few have significant supporting scientific evidence. Some specific foods are linked to specific cancers. Studies have linked eating red or processed meat to an increased risk of breast cancer, colon cancer, prostate cancer, and pancreatic cancer which may be partially explained by the presence of carcinogens in foods cooked at high temperatures.

 

Epidemology and Epigenetics

 

Epidemiology, a well-established corner stone of medical research, it is a group level discipline that aims to decipher the distribution and causes of diseases in populations. Epigenetics is emerging as an important field in cancer epidemiology that promises to provide insights into gene regulation and facilitate cancer control throughout the cancer care continuum. Epigenetic processes are key features in gene regulation. Epigenetic patterns are laid down in early development and are moulded through in utero and early postnatal life and continue to show some degree of plasticity across the life course. Increasingly, investigators are incorporating epigenetic analysis into the studies of etiology and outcomes. Blood cells and tumor tissue were the most commonly used bio specimens in these studies, although buccal cells, cervical cells, sputum, and stool samples were also used. DNA methylation profiling was the focus of the majority of studies, but several studies also measured microRNA profiles.

 

Biopsy

 

An examination of tissue removed from a living body to discover the presence, cause, or extent of a disease. A biopsy is a medical test commonly performed by a surgeon, interventional radiologist, or an interventional cardiologist involving extraction of sample cells for examination to determine the presence or extent of a disease. The tissue is generally examined under a microscope by a pathologist, and can also be analyzed chemically. Main biopsy is Skin biopsy, renal biopsy and breast biopsy. Skin biopsy is a biopsy technique in which a skin lesion is removed to be sent to a pathologist to render a microscopic diagnosis. Renal biopsy is a medical procedure in which a small piece of kidney is removed from the body for examination, usually under a microscope. Several methods for a breast biopsy now exist.

 

Cancer Bioinformatics

 

Cancer is the most common causes of patient death in the clinic and a complex disease occurring in multiple organs per system, multiple systems per organ, or both, in the body. The poor diagnoses of therapies and prognoses of the disease can be mostly due to the variation of severities, durations, locations, sensitivity and resistance against drugs, cell differentiation and origin, and understanding of pathogenesis. Cancer bioinformatics is a critical and important part of the systems clinical medicine in cancer and the core tool and approach to carry out the investigations of cancer in systems clinical medicine. Cancer bioinformatics is expected to play an important role in the identification and validation of biomarkers, specific to clinical phenotypes related to early diagnoses, measurements to monitor the progress of the disease and the response to therapy, and predictors for the improvement of patient’s life quality.

 

Prostate Cancer

 

Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, some grow relatively quickly. The cancer cells may spread from the prostate to other parts of the body, particularly the bones and lymph nodes. It may initially cause no symptoms. In later stages it can lead to difficulty urinating, blood in the urine, or pain in the pelvis, back or when urinating. A disease known as benign prostatic hyperplasia may produce similar symptoms. Prostate cancer screening is controversial. Prostate-specific antigen testing increases cancer detection but does not decrease mortality.

Market Analysis Report

Oncology Meet 2018 with a basic emphasis in the field of cancer/oncology is research studies done which are performed to explore new medical treatments to implement them in people. These play a major role exploration & furtherance of therapies for medical care. People that usually are related with the clinical trial in the field on cancer & oncology are comprises of registered Oncologists, Surgical Oncologists, Scientists, Physicians, Nurses & Clinical specialists working for cancer treatment etc.

 

Importance & Scope

 

Oncology Meet 2018 will cover the entire spectrum of oncology, including prevention, diagnosis, treatment, toxicities of therapy, supportive care, quality-of-life, and survivor-ship issues in the field of cancer & oncology. It will include the use of novel technologies, both in the arena of diagnosis and treatment in the fight against this dreadful disease.This conference will provide clinicians and researchers with a platform to disseminate their personal experiences to a wider public as well as to know interesting cases encountered by colleagues all over the world.

 

Why Paris?

 

Paris, the cosmopolitan capital of France, is one of the largest groups in Europe and the city is a symbol of French culture, with 2.2 million people living in the dense, central city and almost 12 million people living in the whole metropolitan area. Located in the north of France on the river Seine, Paris has the well-deserved status of being the most beautiful and romantic of all cities. It has an annual 30 million foreign visitors, and so is one of the most visited cities in the world. Paris needs no introduction. It’s synonymous with food, culture, fashion, and architecture, rarely unsatisfactory to those who visit. Despite being the dream destination for millions of people each year, the French capital still has plenty hidden secrets to offer beyond the Eiffel Tower and its world-class museums. For centuries, Paris has attracted artists from around the world, who arrive in the city to educate themselves and to seek inspiration from its vast pool of artistic resources and galleries. As a result, Paris has acquired a reputation as the "City of Art". Paris is the home of imperative museums and cultural institutions and to truly understand Paris you have to immerse yourself in the city’s artistic culture. Beyond the Louvre and the Musée d’Orsay, you can get your culture fix at the modernized Picasso Museum and the new Foundation Louis Vuitton, not to mention dozens of small museums and galleries. Paris has more than 421 municipal parks and gardens. The city is also a major rail, highway, and air-transport center, served by the two international airports Paris-Charles de Gaulle and Paris-Orly. Paris has many nicknames, but its most famous is “La Ville-Lumière” (“The City of Light”), a name it owes first to its fame as a Centre of education and ideas during the Age of Enlightenment, and later to its early adoption of street lighting.


 

In Europe

 

  • Translational Research in Oncology
  • Gustave Roussy Institute of Oncology
  • American Hospital of Paris
  • Texas Oncology-Paris
  • Hartmann Clinic
  • Bichat-Claude Bernard Hospital
  • Cancéropole Ile-De-France
  • Institut Curie-Pôle Developmental Biology
  • Saint-Louis Hospital
  • Hospital Group Paris Saint-Joseph

 

Worldwide

 

  • Irish Cancer Society
  • Cancer Research UK
  • Peter McCollum Cancer Centre
  • Cancer Society of New Zealand
  • American Society of Clinical Oncology (ASCO)
  • International Agency for Research on Cancer (IARC)
  • American Association for Cancer Research (AACR)
  • International Cancer Research Partnership (ICRP)
  • National Cancer Institute (NIC)
  • The European Cancer Organization (ECCO)
  • Medical Centre Cologne
  • German Cancer Research Center

Hospitals associated on Oncology:


In Europe

 

  • Leiden University Medical Center
  • Royal Cancer Hospital
  • King’s College Hospital
  • Clatterbridge Center for Oncology
  • Northampton General Hospital
  • Cambridge University Hospitals
  • University Hospital Southhampton
  • Central Manchester University Hospitals
  • Southend University Hospital
  • Kingston Hospitals
  • Bradford Hospital
  • Institute of Oncology, Ljubljana
  • Institut Gustave Roussy, Paris
  • Paterson Institute on Cancer Research, UK
  • Christie Hospitals
  • Wellington Hospital
  • Imperial College Hospital
  • Curie Institute
  • The Royal Marsden Hospital in London, England



In USA

 

  • New York Presbyterian Hospital
  • Memorial Sloan Kettering Cancer Center
  • Mayo Clinic Rochester
  • MD Anderson Cancer Center, Texas
  • John Hopkins Hospital, Baltimore
  • University of Washington Medical Center
  • Massachusetts General Hospital
  • UCSF Medical Center
  • UCLA Medical Center
  • Stanford Hospital
  • City of Hope,CA
  • University of Colorado Hospital
  • Institute of Cancer Research.London
  • Dana-Farber Cancer Institute in Boston, USA
  • Memorial Sloan Kettering (MSK) Cancer Center, New York City
  • Hospitals of the University of Pennsylvania–Penn Presbyterian, Philadelphia
  • Cleveland Clinic
  • Seidman Cancer Center at UH Case Medical, Cleveland
  • University of Colorado Hospital, Denver
  • Hackensack University Medical Center – Hackensack, New Jersey
  • Georgetown University Medical Center (Washington, D.C.)
  • Montefiore Medical Center (New York City)
  • The Toledo (Ohio) Hospital.
  • University of Iowa Hospitals and Clinics (Iowa City).
  • University of Virginia Medical Center (Charlottesville)
  • Yale-New Haven (Conn.) Hospital.


 


Market Analysis Report

 

The pace of change in cancer care is accelerating. A cluster of innovative treatments, often combined with other new or existing medicines, and frequently associated with biomarkers, are emerging from the research and development pipeline.

 

Over the past five years, 70 new oncology treatments have been launched and are being used to treat over 20 different tumour types.

Annual global growth in the oncology drug market is expected to be 7.5 - 10.5 % through 2020, reaching $150 billion. Wider utilization of new products especially immunotherapies will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes.

 

Oncology drug costs relative to total drug costs range from 2.5% in the case of India to almost 16% in the case of Germany and France. In the U.S., cancer drugs account for 11.5% of total drug costs in 2015, up from 10.5% in 2011.

 

The total cost of cancer therapeutics and medicines used in supportive care-measured at the ex-manufacturer price level before the application of rebates or other price concessions - reached $107 billion in 2015, representing an increase in constant dollars of 11.5% over the prior year.

To Collaborate Scientific Professionals around the World

Conference Date July 23-24, 2018
Speaker Oppurtunity Day 1
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Venue
&
Hospitality

Paris, France

Join The Discussion

Contact Desk

Sponsorship & Exhibitors Queries

Viana Shelton

oncology@alliedmeetings.org

+44 800 086 8979

Conference Brochure Queries

Viana Shelton

oncologymeet@alliedconference.com

+44 800 086 8979

Special Issues
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
Media Partners

Allied Academies Global Conference Directory

Mail us at

General Queris
oncologymeet@alliedconferences.org
Sponsorship & Exhibitors Queries
oncology@alliedmeetings.org
Conference Brochure Queries
oncologymeet@alliedconference.com
More details about sponsorship:sponsors@alliedacademies.com

Highlights from last year's Convention

Copyright © 2017-2018 Allied Academies, All Rights Reserved.